Research Funding

Glycoscience

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)

8/4/17 RFA-RM-17-029 Karl E. Krueger
kruegerk@mail.nih.gov
240 276-7026
Letter of intent:
30 days prior to the application due date
Receipt Date:
10/27/2017
Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01) 8/4/17 RFA-RM-17-030 Karl E. Krueger
kruegerk@mail.nih.gov
240 276-7026
Letter of intent:
30 days prior to the application due date
Receipt Date:
10/27/2017

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

NIH Director's Early Independence Awards (DP5)

4/18/17 RFA-RM-17-008 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
Letter of intent:
8/22/2017
Receipt Date:
9/22/2017
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

NIH Director's New Innovator Award Program (DP2)

4/20/17 RFA-RM-17-006 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
Letter of intent:
N/A
Receipt Date:
9/8/2017
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 

 

High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

NIH Director's Pioneer Award Program (DP1)

4/20/17 RFA-RM-17-005 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
Letter of intent:
N/A
Receipt Date:
9/1/2017
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 

 

High-Risk Research: NIH Director's Transformative Research Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

NIH Director's Transformative Research Awards (R01)

4/20/17 RFA-RM-17-007 Ravi Basavappa
Transformative_Awards@mail.nih.gov
301 435-7204
Letter of intent:
N/A
Receipt Date:
9/15/2017

 

Metabolomics

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Notice of a Pre-Application Webinar for the Common Fund Metabolomics Program Stage 2 FOAs (RFA-RM-17-011, RFA-RM-17-012, RFA-RM-17-013, and RFA-RM-17-014) 8/7/2017 RFA-RM-17-036 Barbara A. Spalholz
spalholb@mail.nih.gov
240-276-6230
Pre-registration Required

National Metabolomics Data Repository (NMDR) (U2C)

8/1/2017 RFA-RM-17-011 Arthur L. Castle
castlea@mail.nih.gov  
301-594-7719
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Metabolomic Data Analysis and Interpretation Tools (U01)

8/1/2017 RFA-RM-17-012 Krista A. Zanetti
zanettik@mail.nih.gov
240-276-6843
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Compound Identification Development Cores (U2C)

8/1/2017 RFA-RM-17-013 David Balshaw
balshaw@niehs.nih.gov
919-541 2448
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)

8/1/2017 RFA-RM-17-014 Arthur L. Castle
castlea@mail.nih.gov  
301-594-7719
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

 

Stimulating Peripheral Activity to Relieve Conditions (SPARC)

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2)

4/11/17 RFA-RM-17-010 Michael B. Wolfson 
SPARC_NextGen-Tools@mail.nih.gov 
See RM-17-009
Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) 11/17/2015 RFA-RM-15-018 Jill L. Carrington
carringj@mail.nih.gov
301 402-0671
See RFA-RM-15-003
Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT1) 3/17/17 RFA-RM-17-009 Michael B. Wolfson 
Andrew C. Weitz 
SPARC_NextGen-Tools@mail.nih.gov
Receipt Date:
5/1/2017
8/1/2017
11/1/2017
2/1/2018
5/1/2018
8/1/2018
11/1/2018

 

Undiagnosed Diseases Network

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)

8/15/17 RFA-RM-17-015 Tiina Urv
urvtiin@mail.nih.gov
301-827-2746
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17     RFA-RM-17-016     Jyoti Dayal
jyotig@mail.nih.gov
301-480-2307
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017

Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)

8/15/17 RFA-RM-17-017 Laura Mamounas
mamounas@ninds.nih.gov
301-496-5745
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17 RFA-RM-17-018 Anastasia L. Wise
anastasia.wise@nih.gov
301- 480-3517
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17 RFA-RM-17-019 Anastasia L. Wise
anastasia.wise@nih.gov
301- 480-3517
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
 

 

Past Funding Opportunities

This page last reviewed on August 17, 2017